Caiping Gao

1.0k total citations
21 papers, 820 citations indexed

About

Caiping Gao is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Caiping Gao has authored 21 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Surgery and 8 papers in Genetics. Recurrent topics in Caiping Gao's work include Inflammatory Bowel Disease (8 papers), IL-33, ST2, and ILC Pathways (5 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). Caiping Gao is often cited by papers focused on Inflammatory Bowel Disease (8 papers), IL-33, ST2, and ILC Pathways (5 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). Caiping Gao collaborates with scholars based in China, United States and Israel. Caiping Gao's co-authors include Hong Lü, Shudong Xiao, Wenzhong Liu, Zhiyu Zhang, Jianjun Chen, Ping Chen, Zejuan Li, Jinxia Wang, David Y. Graham and Ting Zhang and has published in prestigious journals such as Cancer, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Caiping Gao

19 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caiping Gao China 11 496 488 215 99 75 21 820
Yunben Yang China 12 755 1.5× 799 1.6× 129 0.6× 75 0.8× 90 1.2× 12 1.1k
Annamaria Gentile Italy 12 213 0.4× 358 0.7× 187 0.9× 64 0.6× 85 1.1× 28 636
Vânia Camilo Portugal 12 60 0.1× 223 0.5× 318 1.5× 134 1.4× 97 1.3× 23 612
Samaneh Saberi Iran 12 89 0.2× 119 0.2× 190 0.9× 95 1.0× 41 0.5× 40 361
Ian J. Bristol United States 10 155 0.3× 209 0.4× 245 1.1× 240 2.4× 44 0.6× 13 798
Alejandra Mantilla Mexico 10 100 0.2× 461 0.9× 280 1.3× 87 0.9× 148 2.0× 23 740
Aki Sakatani Japan 13 203 0.4× 335 0.7× 113 0.5× 40 0.4× 113 1.5× 36 617
Yunfei Zuo China 14 169 0.3× 332 0.7× 66 0.3× 141 1.4× 79 1.1× 37 633
Seth R. Ogden United States 7 46 0.1× 185 0.4× 299 1.4× 194 2.0× 71 0.9× 7 496
Alban Giese France 13 53 0.1× 145 0.3× 186 0.9× 157 1.6× 58 0.8× 21 468

Countries citing papers authored by Caiping Gao

Since Specialization
Citations

This map shows the geographic impact of Caiping Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caiping Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caiping Gao more than expected).

Fields of papers citing papers by Caiping Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caiping Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caiping Gao. The network helps show where Caiping Gao may publish in the future.

Co-authorship network of co-authors of Caiping Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Caiping Gao. A scholar is included among the top collaborators of Caiping Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caiping Gao. Caiping Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Yan, Tingting Wang, Zhou Zhou, et al.. (2025). Kurarinone ameliorates intestinal mucosal inflammation via regulating T cell immunity. Frontiers in Immunology. 16. 1587479–1587479.
2.
Xiao, Xiao, Binghong Li, Jinxia Wan, et al.. (2025). Helicobacter pylori infection might be a protective factor against Parkinson’s disease. Scientific Reports. 15(1). 16689–16689.
3.
Pan, Yan, An Li, Zhou Zhou, et al.. (2024). Association between serum omentin-1 and mucosal disease activity in patients with ulcerative colitis. Postgraduate Medical Journal. 100(1183). 327–333. 2 indexed citations
4.
Liu, Ya, et al.. (2023). Clinical significance of the C-reactive protein-to-bilirubin ratio in patients with ulcerative colitis. Frontiers in Medicine. 10. 1227998–1227998. 4 indexed citations
5.
Pan, Yan, Ya Liu, Zhou Zhou, et al.. (2023). Clinical Utility of the Neutrophil-to-Bilirubin Ratio in the Detection of Disease Activity in Ulcerative Colitis. Journal of Inflammation Research. Volume 16. 2549–2559. 2 indexed citations
6.
Pan, Yan, Zhou Zhou, Xue Yang, et al.. (2023). Clinical significance of a novel uric-acid-based biomarker in the prediction of disease activity and response to infliximab therapy in Crohn’s disease. Scandinavian Journal of Gastroenterology. 58(7). 737–743. 3 indexed citations
7.
Zhou, Zhou, Yinghui Zhang, Yan Pan, et al.. (2022). A Novel Neutrophil-Based Biomarker to Monitor Disease Activity and Predict Response to Infliximab Therapy in Patients With Ulcerative Colitis. Frontiers in Medicine. 9. 872831–872831. 9 indexed citations
8.
Zhang, Gao, Kun Peng, Yanping Gao, et al.. (2022). Carnosol Maintains Intestinal Barrier Function and Mucosal Immune Homeostasis in DSS-Induced Colitis. Frontiers in Nutrition. 9. 894307–894307. 13 indexed citations
9.
10.
Xiang, Lu, et al.. (2021). The Serum Citrulline and D-Lactate are Associated with Gastrointestinal Dysfunction and Failure in Critically Ill Patients. International Journal of General Medicine. Volume 14. 4125–4134. 10 indexed citations
11.
Gao, Caiping, Di Zhang, Ting Zhang, et al.. (2020). PPI‐amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta‐analysis. Helicobacter. 25(4). e12692–e12692. 75 indexed citations
12.
Yang, Xue, et al.. (2019). High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment. Medicine. 98(7). e14396–e14396. 42 indexed citations
13.
Xiao, Jie, et al.. (2019). Sauchinone ameliorates intestinal inflammation and promotes Th17 cell production of IL-10 via Blimp-1. Biochemical and Biophysical Research Communications. 522(2). 435–441. 22 indexed citations
14.
Qian, Yi, Jinxia Wang, Zhenzhen Guo, et al.. (2019). Ascl2 facilitates IL-10 production in Th17 cells to restrain their pathogenicity in inflammatory bowel disease. Biochemical and Biophysical Research Communications. 510(3). 435–441. 15 indexed citations
15.
Yang, Xue, Zhenzhen Guo, Fei Xiong, et al.. (2018). MicroRNA-425 facilitates pathogenic Th17 cell differentiation by targeting forkhead box O1 (Foxo1) and is associated with inflammatory bowel disease. Biochemical and Biophysical Research Communications. 496(2). 352–358. 36 indexed citations
16.
Gao, Caiping, et al.. (2018). High-dose amoxicillin/esomeprazole dual therapy as a first-line therapy for Helicobacter pylori eradication. World Chinese Journal of Digestology. 26(6). 353–353. 10 indexed citations
17.
Gao, Caiping, Minghui Pang, Zhou Zhou, et al.. (2014). Epidermal growth factor receptor-coamplified and overexpressed protein (VOPP1) is a putative oncogene in gastric cancer. Clinical and Experimental Medicine. 15(4). 469–475. 17 indexed citations
18.
Gao, Caiping, et al.. (2010). [Reduced expression of miR-218 and its significance in gastric cancer].. PubMed. 32(4). 249–52. 4 indexed citations
19.
Gao, Caiping, et al.. (2009). Reduced microRNA‐218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer. 116(1). 41–49. 134 indexed citations
20.
Zhang, Zhiyu, Zejuan Li, Caiping Gao, et al.. (2008). miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Laboratory Investigation. 88(12). 1358–1366. 413 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunben Yang Breakdown of academic impact, for papers by Annamaria Gentile Breakdown of academic impact, for papers by Vânia Camilo Breakdown of academic impact, for papers by Samaneh Saberi Breakdown of academic impact, for papers by Ian J. Bristol Breakdown of academic impact, for papers by Alejandra Mantilla Breakdown of academic impact, for papers by Aki Sakatani Breakdown of academic impact, for papers by Yunfei Zuo Breakdown of academic impact, for papers by Seth R. Ogden Breakdown of academic impact, for papers by Alban Giese
Rankless by CCL
2026